ARCHIVES

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Accrediting Agency Places Dana-Farber On Probation

April 21, 1995

Longmire Reappointed To Cancer Panel

April 8, 1988

Upton Promises “Minimal Disruption” As Result of Changes; Centers Program Probably To Move

January 20, 1978

NCI advisors approved in concept the Institute’s plan to spend $24 million over five years for research on “patient navigator” programs.

March 26, 2004

Shared Decisionmaking Called For In PSA Screening For Ages 55-69

May 31, 2013

In Brief: Cancer Control To Push Environmental Research Occupational Hazards; Bailer to Journal Post

May 24, 1974